Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Luis Armando Caicedo is active.

Publication


Featured researches published by Luis Armando Caicedo.


International Journal of Surgery Case Reports | 2017

Sclerosing Encapsulated Peritonitis: A devastating and infrequent disease complicating kidney transplantation, case report and literature review

Liliana Caicedo; Alejandro Delgado; Luis Armando Caicedo; Juan Carlos Bravo; Laura S. Thomas; Martin Rengifo; Jorge I. Villegas; Oscar Serrano; Gabriel J. Echeverri

Highlights • Sclerosing encapsulating peritonitis is a rare and dangerous complication.• Kidney transplanted patients with peritoneal dyalisis history are in risk of SEP.• Adhesiolisis is the ideal surgical management for Sclerosing encapsulating peritonitis.


International Journal of Surgery Case Reports | 2016

Liver Angiosarcoma: Rare tumour associated with a poor prognosis, literature review and case report.

Mauricio Millán; Alejandro Delgado; Luis Armando Caicedo; Ana María Arrunátegui; Carlos A. Meneses; Jorge I. Villegas; Oscar Serrano; Liliana Caicedo; Mauricio Duque; Gabriel J. Echeverri

Highlights • Liver Angiosarcoma is rare and aggressive tumour that requires surgical management.• Partial Hepatectomy is the ideal surgical management for Liver Angiosarcoma.• Liver transplant does not improve the survival of Liver Angiosarcoma patients.


Transplant Infectious Disease | 2018

Hepatitis A, cardiomyopathy, aplastic anemia, and acute liver failure: A devastating scenario

Verónica Botero; Víctor H. García; Ana M. Aristizabal; Catalina Gómez; Paola Perez; Luis Armando Caicedo; Gabriel J. Echeverri

Hepatitis A virus (HAV) causes an acute infection and is usually asymptomatic in children. When clinical manifestations appear, these include choluria, jaundice, and abdominal pain. Although infrequent, extra‐hepatic manifestations related to HAV have been described, affecting the heart, bone marrow, blood vessels, and other tissues.A 10‐year‐old boy from a rural area presented with a 15‐day history of malaise, fever, and jaundice; laboratory examinations were compatible with HAV infection. The patient turned encephalopathic and was remitted to our center, where laboratory examinations showed a medullary aplasia and fulminant hepatitis requiring a liver transplant that was performed 72 hours after admission. At 24 hours post transplant, the patient developed a cardiomyopathy secondary to HAV, and intravenous immunoglobulin was administered. The patient is still alive and attending his medical check‐ups.Although rare, extra‐hepatic manifestations of HAV infection have been described in 14% of cases. The groups of patients affected are usually aged and present with high bilirubin levels. Acquired aplastic anemia and myocarditis caused by HAV are uncommon, and its pathophysiology has not yet been elucidated.HAV infection is usually asymptomatic in children, although extra‐hepatic manifestations can appear requiring early detection and management.


Transplantation direct | 2017

Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center

Luis Armando Caicedo; Angie Sabogal; Oscar Serrano; Jorge I. Villegas; Verónica Botero; María T. Agudelo; Viviana Lotero; Diana Dávalos; Eliana Manzi; Ana M. Aristizabal; Catalina Gómez; Gabriel J. Echeverri

Background Hepatoblastoma is the most common primary malignant liver tumor in children and is usually diagnosed during the first 3 years of life. Overall survival has increased 50% due to chemotherapeutic schemes, expertise surgery centers, and liver transplantation. Methods A retrospective collection of data was performed from pediatric patients with diagnosis of hepatoblastoma. Variables included demographic, diagnostic tools and histological classification; chemotherapy and surgical treatment; and outcomes and patient survival. The PRETEXT classification was applied, which included the risk evaluation, and according to the medical criterion in an individualized way, underwent resection or transplant. The morbidity of patients was evaluated by the Clavien-Dindo classification. Statistical analysis was performed according to the distribution of data and the survival analysis was carried out using the Kaplan-Meier method. Results The patients (n = 16) were divided in a resection group (n = 8) and a transplant group (n = 8). The median age at the time of diagnosis was 13.5 months. The motive for the initial consultation was the discovery of a mass; all patients had high levels of &agr;-fetoprotein and an imaging study. Ten of 16 patients required chemotherapy before the surgical procedure. In the resection group, 5 of 8 patients were classified as Clavien I and 4 of 8 patients of the transplant group were classified as Clavien II. Patient survival at 30 months was 100% in the resection group and 65% in the liver transplantation group. Conclusions To our knowledge, this is the first case report of pediatric patients with hepatoblastoma and liver resection or transplant in Colombia and Latin America. Our results are comparable with the series worldwide, showing that resection and transplant increase the survival of the pediatric patients with hepatoblastoma. It is important to advocate for an increase of reporting in the scientific literature in Latin America.


Cirugia Espanola | 2017

Xenotrasplantes, una realidad cercana en la práctica clínica: revisión de la literatura

Ana M. Aristizabal; Luis Armando Caicedo; Juan Manuel Martos Martínez; Manuel Moreno; Gabriel J. Echeverri

Xenotransplantation could provide an unlimited supply of organs and solve the current shortage of organs for transplantation. To become a reality in clinical practice, the immunological and physiological barriers and the risk of xenozoonosis that they possess should be resolved. From the immunological point of view, in the last 30 years a significant progress in the production of transgenic pigs has prevented the hyperacute rejection. About xenozoonosis, attention has been focused on the risk of transmission of porcine endogenous retroviruses; however, today, it is considered that the risk is very low and the inevitable transmission should not prevent the clinical xenotransplantation. Regarding the physiological barriers, encouraging results have been obtained and its expected that the barriers that still need to be corrected can be solved in the future through genetic modifications.


Transplantation Proceedings | 2018

Liver Transplantation in Hepatitis C–Infected Patients: Experience From a South American Transplant Center

Luis Armando Caicedo; Alejandro Delgado; Víctor H. García; Ana M. Aristizabal; C. Gomez; Diego Jiménez; M. Sepulveda; J.A. García; F. Rosso; A.M. Castro; K. Alcazar; Jorge I. Villegas; Oscar Serrano; Gabriel J. Echeverri

BACKGROUND Around 2.4% of the worlds population is infected with hepatitis C virus (HCV), and it is the most common cause of liver transplantation (LT) in the world. Latin America (LA), with nearly 9% of the world population, has had a continuous increase in the number of LTs per year. Yet, due to the lack of mandatory data collection and a well-developed health-care system, access to transplantation is limited in most LA countries. We report the first LA experience of HCV-infected LT patients. METHODS We performed a retrospective cohort study by reviewing the medical histories of all HCV-infected LT patients between 1996 and 2016 who acquired HCV before their LT, at the Fundación Valle del Lilí, Cali, Colombia. RESULTS Between January 1996 and December 2015, a total of 770 LTs were performed, of which 75 had a cirrhotic liver due to HCV infection. With a median follow-up time of 24.4 months (interquartile range [IQR] 4.7-61.2 months), patient survival was 44.9% and 66.9% for the time periods 1996-2006 and 2007-2015, respectively. Hepatocellular carcinoma (HCC) was present in 30.6% of the patients, and overall postoperative complications had an incidence of 80%. CONCLUSIONS This is the first report of LT in HCV-infected patients in Colombia and in LA. Our results are comparable to those of other transplant centers worldwide with regard to postoperative complications and patient survival. Patients with LT in the 1996-2006 time frame had higher morbidity and mortality. Studies including larger numbers of patients are needed to determine the reason for this finding.


Revista Colombiana de Cirugía | 2018

Donantes de órganos en muerte cerebral por herida por proyectil de arma de fuego en cráneo: una trágica realidad que beneficia receptores de órganos en Colombia

Ana M. Aristizabal; Catalina Gómez-Duarte; Víctor H. García; Eliana Manzi; Carlos Escobar; Juan David Jaramillo; Karen Torres; Mauricio Millán; Luis Armando Caicedo; Gabriel J. Echeverri

Background and objectives: Patients with brain death (BD) due to traumatic brain injury (TBI) secondary to a gunshot (GS) wound in the skull contribute to mitigate the demand for organ and tissue donors. In Colombia, 78% of the homicides are by GS. We describe our experience with BD secondary to TBI by GS organ and tissue donors at a transplant center in Cali, Colombia. Materials and methods: This is a retrospective historical cohort study for characterization of donors diagnosed with BD secondary to TBI by GS at our institution in the period 2010-2016 (n=169). Qualitative variables were assessed by proportions, continuous quantitative variables with measures of central tendency, and survival with


Clinical Transplantation | 2017

Biliary strictures complicating liver transplantation in pediatric patients: Experience in a South American transplant center.

Alfonso J. Holguín; Sara Yukie Rodriguez-Takeuchi; Laura Ospina; Diana Acosta; Verónica Botero; Laura S. Thomas; Jorge I. Villegas; Gabriel J. Echeverry; Luis Armando Caicedo

To describe the experience of percutaneous transhepatic cholangiography (PTC) with biliary dilatation and drainage after pediatric liver transplantation and to determine the long‐term outcome of this procedure.


Case Reports in Gastroenterology | 2017

Liver Transplantation for Unresectable Metastases from Colon Adenocarcinoma

Luis Armando Caicedo; Diego Buitrago; Laura S. Thomas; Jorge I. Villegas; Mauricio Duque; Oscar Serrano; Ana María Arrunátegui; Juan Guillermo Restrepo; Gabriel J. Echeverri

Liver transplantation is an option that improves quality of life and prolongs life expectancy in patients with different types of liver disease. Liver transplantation is controversial for colorectal metastases and is not recommended in clinical practice guidelines. In this case report, we present, to our knowledge, the first liver transplantation for colorectal metastases conducted in Colombia, with a successful follow-up of more than 2 years. Patients with these characteristics who underwent liver transplantation experience reduced mortality and exponentially improved quality of life.


American Journal of Case Reports | 2017

En-Bloc Transplant of the Liver, Kidney and Pancreas: Experience from a Latin American Transplant Center

Luis Armando Caicedo; Jorge I. Villegas; Oscar Serrano; Mauricio Millán; Mauricio Sepúlveda; Diego Jiménez; Jairo García; Juan Guillermo Posada; Liliana Mesa; Carlos Durán; Johanna Schweineberg; Diana Dávalos; Eliana Manzi; Angie Sabogal; Ana M. Aristizabal; Gabriel J. Echeverri

Case series Patient: Male, 38 • Male, 48 Final Diagnosis: En-bloc transplantation (liver, kidney, pancreas) Symptoms: Encephalopathy • adynamia • ascites • asthenia Medication: — Clinical Procedure: En-bloc transplantation Specialty: Transplantology Objective: Unusual setting of medical care Background: En-bloc transplantation is a surgical procedure in which multiple organs are transplanted simultaneously. It has some similarities with multi-organ transplantation but offers certain advantages. This report highlights the experience of our interdisciplinary group regarding the treatment and follow-up of patients who received en-bloc transplantation, with the aim of encouraging the development of this surgical technique. Case Report: The first case is a 38-year-old patient with type 1 diabetes mellitus, liver cirrhosis, and chronic kidney failure who received an en-bloc transplant of the liver, pancreas, and kidney with no intraoperative complications. He had a prolonged hospital stay due to anemia and systemic inflammatory response syndrome, which were resolved successfully. At follow-up, he had no requirement for insulin or for dialysis, or for new interventions. The second case describes a 48-year-old patient with type 2 diabetes mellitus, renal failure, and liver cirrhosis who received an en-bloc transplant of the liver, pancreas, and kidney with no complications. During the postoperative period, the patient suffered a possible episode of acute tubular necrosis, which evolved towards improvement, with a tendency to normal metabolic and renal functioning, with no additional events. The patient is currently in follow-up and is insulin-independent. Conclusions: En-bloc transplantation is a safe procedure, which is technically simple and which achieves excellent results. This procedure is indicated in patients with end-stage renal disease, cirrhosis, and diabetes mellitus that is difficult to control.

Collaboration


Dive into the Luis Armando Caicedo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge